Jim Datin's guest appearances

Jim Datin

High Value Sales Show by Eversprint.com

Molecular Moments Podcast

Tim Bratz

Kevin Markarian

Jesse Cole

Jay Morrison

Tom Douglas

Sujan Patel

Tim Wallace

Hiten Shah

Dave Williams

Ryan Wright

David Johnson

Greenback Expat

John Bennett

Sam Khorramian

Bob Cooper

OwlTail

On this episode of Molecular Moments, BioAgilytix Chief Scientific Officer Jim McNally chats with the company’s President &amp; CEO about the exciting new updates that are putting BioAgilytix at the forefront of biotech on a global level. From multiple acquisitions to a new investor that sees the bigger picture, Datin shares how these opportunities came to be and what major deciding factors came into play when finalizing the acquisitions. The two biotech companies acquired, MicroConstants in San Diego, California, and 360biolabs in Melbourne and Brisbane Australia, are leaders in bioanalysis, and both are aligned with the BioAgilytix core values: Integrity, Customer Experience, Accountability, Respect, and Employee Experience.  They also discuss BioAgilytix’s new London-based investor Cinven, which will create the opportunity to grow BioAgiliytix through additional acquisitions, building additional campuses, ensuring state-of-the-art equipment at all locations, and the opportunity for professional development. See omnystudio.com/listener for privacy information.

On this episode of Molecular Moments, BioAgilytix Chief Scientific Officer Jim McNally chats with the company’s President &amp; CEO about the exciting new updates that are putting BioAgilytix at the forefront of biotech on a global level. From multiple acquisitions to a new investor that sees the bigger picture, Datin shares how these opportunities came to be and what major deciding factors came into play when finalizing the acquisitions. The two biotech companies acquired, MicroConstants in San Diego, California, and 360biolabs in Melbourne and Brisbane Australia, are leaders in bioanalysis, and both are aligned with the BioAgilytix core values: Integrity, Customer Experience, Accountability, Respect, and Employee Experience.   They also discuss BioAgilytix’s new London-based investor Cinven, which will create the opportunity to grow BioAgiliytix through additional acquisitions, building additional campuses, ensuring state-of-the-art equipment at all locations, and the opportunity for professional development. See <a href="https://omnystudio.com/listener" rel="nofollow" target="_blank">omnystudio.com/listener</a> for privacy information.

President & CEO Jim Datin Talks Company Culture, Core Values, and Global Growth!

Jim Datin, the CEO of BioAgilytix, grew his company's revenue from $10.4 million in 2014 to $35.9 million in 2017, a 245% increase, and to just under $60 million in 2018.   BioAgilytix is a bioanalytical testing laboratory specializing in large molecule bioanalysis.   In this interview with Eversprint's Malcolm Lui, Jim shares how he and his team accelerated their high value sales by:   Building a team of renowned experts who put customers first, as indicated by their 99% customer retention rate.  Riding the trend toward large molecule bioanalysis that is expected to continue for years to come.   Providing a cost effective bioanalytical testing service to the largest pharmaceutical and biotech companies in the world.  

Jim Datin, the CEO of <a href="https://www.bioagilytix.com" rel="nofollow" target="_blank">BioAgilytix</a>, grew his company's revenue from $10.4 million in 2014 to $35.9 million in 2017, a 245% increase, and to just under $60 million in 2018.   BioAgilytix is a bioanalytical testing laboratory specializing in large molecule bioanalysis.   In this interview with <a href="https://eversprint.com/" rel="nofollow" target="_blank">Eversprint</a>'s Malcolm Lui, Jim shares how he and his team accelerated their high value sales by:   <ul><li>Building a team of renowned experts who put customers first, as indicated by their 99% customer retention rate.  </li><li>Riding the trend toward large molecule bioanalysis that is expected to continue for years to come.   </li><li>Providing a cost effective bioanalytical testing service to the largest pharmaceutical and biotech companies in the world.  </li></ul>

Enabling Tomorrow's Breakthroughs Today - Jim Datin of BioAgilytix